Briacell Therapeutics Corp 8BT.SG
$3.21 $0.09 (2.73%) 1D
Last Updated: Mar 13, 12:00 AM·XSTU
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Briacell Therapeutics Corp Stock Halal?
Shariah Compliance Analysis of 8BT.SG Stock
Germany Health Care Nano Cap No. As of September 2026, Briacell Therapeutics Corp (8BT.SG) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Briacell Therapeutics Corp does not pass Musaffa's business and financial screening criteria.
Briacell Therapeutics Corp is a CA-based company operating in Biotechnology industry. The company is headquartered in West Vancouver, British Columbia and currently employs 17 full-time employees. The company went IPO on 2006-10-12. BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The firm is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. The company is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
8BT.SG Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Briacell Therapeutics Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Briacell Therapeutics Corp (8BT.SG) Chart
Financial Metrics & Statements of Briacell Therapeutics Corp (8BT.SG)
FAQ's for Briacell Therapeutics Corp (8BT.SG)
- As of September 2026, Briacell Therapeutics Corp 8BT.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Briacell Therapeutics Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Briacell Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Briacell Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Briacell Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Briacell Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Briacell Therapeutics Corp (8BT.SG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
